Updated: Jul 12, 2025

A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
Patrick B Brady1, Bryan K Sorensen1, Roberto M Risi1
1Centralized Organic Synthesis Group, Small Molecule Therapeutic and Platform Technologies, AbbVie Inc., North Chicago, Illinois 60064, United States.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed a scalable synthesis for ABBV-467, a potent MCL-1 inhibitor for multiple myeloma treatment. This decagram-scale synthesis enables crucial preclinical studies for this complex molecule.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: